In a major strategic move, Probo Medical, a premier global provider of medical imaging solutions, has announced the acquisition of Alpha Source Group, a merger that will notably enhance Probo’s offerings in the biomedical research and life science markets. This definitive purchase agreement is set to significantly bolster Probo’s diagnostic imaging solutions platform.

Founded in 1986, Alpha Source is known for its technical field service, depot repair, equipment refurbishment, and parts distribution solutions, primarily serving the North American healthcare market. The company’s extensive customer base includes original equipment manufacturers (OEMs), independent service organizations (ISOs), asset managers, hospitals, distributors, and resellers. Alpha Source boasts a sizable field service organization, supported by in-house expertise at four Centers of Excellence located across the United States.

Michael Asmer, CEO of Probo Medical, expressed his excitement about the transformative nature of the acquisition. “We’re eager to integrate Alpha Source’s expertise and relationships into our platform, extending our reach into new imaging modalities and enhancing our service offerings,” Asmer said. He highlighted that the merger is expected to scale system refurbishment and resale capabilities, expand parts distribution, and optimize field service delivery on a global scale.

Avista Capital Partners, a leading healthcare-focused private equity firm, backs Probo Medical. With over $8 billion invested in more than 45 growth-oriented healthcare businesses worldwide, Avista’s support underscores the significance of the acquisition in the healthcare industry.

The merger of Probo Medical and Alpha Source Group represents a strategic alignment that is anticipated to drive growth and innovation within the medical technology sector. It signifies a milestone in healthcare service delivery, promising to bring about advancements in medical imaging equipment and services.

  Alpha Source Group, Diagnostic Imaging, Medical Imaging, Michael Asmer, Probo Medical